Cameron Smith-CraigPharma
- Indexed articles, last 90 days
- 9
- Latest publication
- Sep 29, 2026
- Outlet visibility, for Selectscience
- Top 5M sites
- Earliest in this view
- Jul 22, 2026
Latest articles
Preparing EU water labs for TFA and PFAS rules - SelectScience® interview (opens the original)
Read excerpt
Per- and polyfluoroalkyl substances (PFAS) monitoring in European waters is changing, with a new directive extending testing to surface water and groundwater, and bringing trifluoroacetic acid (TFA), one of the smallest and most mobile PFAS, as well as other pesticides, microplastics, and pharmaceuticals that have recently been proven dangerous, into regulatory scope for the first time. For Jana Kováčová, PFAS lead for continental Europe at ALS, constant change and expansion is the nature of the
Preserving CMC decision lineage - SelectScience interview (opens the original)
Read excerpt
Chemistry, manufacturing and controls (CMC) generates enormous quantities of scientific data as a drug candidate moves towards a reproducible, scalable and ultimately manufacturable medicine. Increasingly, the challenge is no longer simply whether CMC data has been digitalized, but whether the scientific knowledge, context and decision-making rationale behind that data remain connected as a product moves through development. From establishing the quality target product profile (QTPP), through pr
How functional proteomics 2.0 is reshaping precision medicine - SelectScience interview (opens the original)
Read excerpt
Your inherited genome is largely stable over a lifetime but it mainly describes biological potential. Proteins tell us much more about what cells are actually doing now. That gap, between a genome's fixed potential and the body's shifting reality, is where the next era of precision medicine is unfolding. Proteomics, not genomics, is closing that gap, and the technology behind it is advancing fast. Dr. Daniel Hornburg, Vice President Biomarkers & Precision Medicine at Bruker Daltonics, has spent
Streamlining multimodal drug discovery with AI-ready data - SelectScience guide (opens the original)
Read excerpt
Modern drug discovery is becoming increasingly multimodal. Alongside traditional small molecules, researchers are advancing protein degraders, antibody-drug conjugates, RNA therapeutics, and cell and gene therapies, each generating unique datasets across chemistry, biology, and translational research. While these modalities offer exciting therapeutic opportunities, they also create new challenges around data management, collaboration, and decision-making. Many organizations continue to rely on d
Preparative LC fundamentals for better purification - SelectScience guide (opens the original)
Read excerpt
Preparative liquid chromatography (prep LC) is a cornerstone of modern purification workflows, enabling scientists to isolate target compounds from complex mixtures for research, development, and manufacturing applications. Whether supporting synthetic chemistry, analytical services, process development, or production environments, successful purification depends on balancing purity, recovery, speed, and scalability. As purification demands grow, scientists face a range of challenges, from optim
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For Selectscience, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.